Atara Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Atara Biotherapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 87% to $8,573,000. Profit margin reached -3221%. Total operating expenses were $275,693,000.
Profit Margin
| 2014 | 0 | -280.06M | |
|---|---|---|---|
| 2015 | 0 | -572.21M | |
| 2016 | 0 | -79.04M | |
| 2017 | 0 | -1.19B | |
| 2018 | 0 | -230.69M | |
| 2019 | 0 | -290.97M | |
| 2020 | 0 | -3.06B | |
| 2021 | 20.34M | -340.14M | -1672.28% |
| 2022 | 63.57M | -228.30M | -359.12% |
| 2023 | 8.57M | -276.12M | -3220.88% |
ATRA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 8.57M | 63.57M | 20.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 8.88M | 14.56M | 11.38M | 9.86M | 8.10M | 3.78M | 956K | 383K | 48K | 0 |
Gross profit | -313K | 49.00M | 8.96M | -9.86M | -8.10M | -3.78M | -956K | -383K | -48K | 0 |
Operating exp. | ||||||||||
Research and development | 224.78M | 272.53M | 282.00M | 244.65M | 216.09M | 167.45M | 81.20M | 56.51M | 41.61M | 15.44M |
Selling and marketing | -1.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 275.69M | 344.08M | 360.80M | 309.05M | 295.68M | 237.11M | 121.53M | 81.24M | 58.44M | 28.15M |
Operating income | -276.00M | -280.51M | -340.46M | -309.05M | -295.68M | -237.11M | -121.53M | -81.24M | -58.44M | -28.15M |
Other income (expenses), net | -105K | 52.22M | 367K | 2.44M | 4.71M | 6.36M | 2.02M | 2.20M | 1.21M | 125K |
Income before tax | -276.11M | -228.29M | -340.09M | -306.60M | -290.96M | -230.74M | -119.50M | -79.03M | -57.23M | -28.03M |
Income tax expense | 15K | 12K | 46K | 15K | 12K | -44K | -14K | 10K | -9K | -25K |
Net income | -276.12M | -228.30M | -340.14M | -3.06B | -290.97M | -230.69M | -1.19B | -79.04M | -572.21M | -280.06M |
Earnings per share | ||||||||||
Basic EPS | -65.18 | -2.24 | -3.63 | -103.63 | -5.67 | -5.27 | -100.03 | -2.75 | -55.92 | -140.42 |
Diluted EPS | -65.18 | -2.24 | -3.63 | -103.63 | -5.67 | -5.27 | -100.03 | -2.75 | -55.92 | -140.42 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |